Africa, India test sites for anti-HIV microbicide. Cellulose sulfate tested in high-risk women.
Phase III effectiveness clinical trials have begun for the potential anti-HIV microbicide cellulose sulfate (Ushercell), formerly called C31G, which already has demonstrated safety when used by women. If the trials go well, the product could be ready for approval by the FDA by 2010.
D000349:Africa; D019380:Anti-HIV Agents / Q000008:administration & dosage*; D002482:Cellulose / Q000008:administration & dosage* / Q000031:analogs & derivatives*; D017326:Clinical Trials, Phase III as Topic; D005260:Female; D015658:HIV Infections / Q000517:prevention & control* / Q000635:transmission*; D006801:Humans; D007194:India; D011209:Power, Psychological; D012307:Risk Factors
D019380:Anti-HIV Agents; D002482:Cellulose; C020254:cellulose sulfate